Tissue Diagnostics Market to be Worth $8.52 Billion by 2029

According to this latest publication from Meticulous Research, the global tissue diagnostics market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4%. The rising prevalence of cancer globally, the availability of biomarkers and research on biomarkers, recommendations for cancer screening, the growing number of clinical trials for oncology drugs, and the availability of tissue-based companion diagnostics are the factors driving the growth of this market.

Download Free PDF Sample Copy of the Report (with COVID-19 Impact TissueScopehttps://www.meticulousresearch.com/download-sample-report/cp_id=4971Analysis):oftheReport:DiagnosticsMarket,byProductType  Consumables o Antibodies o Kits o Reagents  Instruments o Slide Staining Systems o Slide Scanners Page 1 of 5

© Meticulous Research| sales@meticulousresearch.com Tissue Diagnostics Market - 2029 Meticulous Research®—a leading global market research company, published a research report titled, ‘Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), End user-GlobalForecastto2029’.

© Meticulous Research| sales@meticulousresearch.com Tissue Diagnostics Market - 2029 o Tissue Processors o Other Instruments Note: Other instruments include microarrays and embedding systems. TissueDiagnosticsMarket,byTechnology  Immunohistochemistry (IHC)  In-situ Hybridization (ISH)  Digital Pathology  H&E Slide Staining  Other Technologies Note: Other technologies include molecular, immunofluorescence, and special staining TissueDiagnosticsMarket,byApplication  Breast Cancer  Lung Cancer  Colorectal and Gastrointestinal Cancer  Prostate Cancer  Lymphatic Cancer  Other Applications Note: Other applications include cervical cancer, melanoma, lip, oral cavity cancer TissueDiagnosticsMarket,byEndUser  Hospitals and Reference Laboratories  Research Institutes  Pharmaceutical Companies  Contract Research Organization TissueDiagnosticsMarket,byGeography  North America o U.S. o Canada  Europe o Germany o U.K. o France o Italy o Spain o Rest of Europe (RoE)  Asia-Pacific (APAC) Page 2 of 5

Page 3 of 5

Based on product, in 2022, the consumables segment is expected to account for the largest share of the market. The extensive and recurring requirement of consumables and technological advances in developing novel reagents contribute to the large market share of this segment.

The global tissue diagnostics market is segmented by Product Type (Consumables [Antibodies, Kits, Reagents], Instruments [Slide Staining Systems, Slide Scanners, Tissue Processing Systems, Other Instruments {Microarray, Embedding System]), Technology (Immunohistochemistry, In-situ Hybridization, Digital Pathology, H&E Slide Staining, Other Technologies, Application (Breast Cancer, Lung Cancer, Colorectal and Gastrointestinal Cancer, Prostate Cancer, Lymphatic Cancer, Other Applications), End User (Hospitals and Reference Laboratories, Research Institutes, Pharmaceutical Companies, and Contract Research Organization). The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.



Basedreport/cp_id=4971RequestSampleReport:https://www.meticulousresearch.com/request-sample-onapplication, the tissue diagnostics market is segmented into breast cancer, lung cancer, colorectal and gastrointestinal cancer, prostate cancer, lymphatic cancer, and other applications. In 2022, the breast cancer segment is expected to account for the largest share of the global tissue diagnostics market. The growth of this segment is attributed to the high prevalence of breast cancer and the presence of several research and screening programs for combating breast cancer.

Based on technology, the tissue diagnostics market is segmented into immunohistochemistry, in-situ hybridization, digital pathology, H&E staining, and other technologies. In 2022, the immunohistochemistry segment is expected to account for the largest share of the global tissue diagnostics market. Developments in in-vitro diagnostics and the upsurge in point-of-care diagnostics are the factors contributing to the growth of this segment.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/tissueTissuediagnostics-market-4971DiagnosticsMarket:FutureOutlook

Basedonenduser, in 2022, the hospital and reference laboratories segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high inflow of patients and tests due to the increasing prevalence of Thiscancer.research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the tissue diagnostics market The large market share of this regional market is driven by the high cancer prevalence, easy accessibility to advanced technologies, and the presence of public programs for cancer management.

Tissue Diagnostics Market - 2029 o China o Japan o India o

You

 What

KeyquestionsansweredinthereportWhich are the high-growth market segments in terms of product type, technology, application, end user, and regions/countries? was the historical market for tissue diagnostics across the globe? What are the market forecasts and estimates for the period 2022–2029? are the major drivers, restraints, challenges, opportunities, and trends in the global tissue diagnostics market? are the major players in the global tissue diagnostics market? is the competitive landscape, and who are the market leaders in the global tissue diagnostics market? are the recent developments in the tissue diagnostics market? are the different strategies adopted by the major players in the tissue diagnostics market? are the geographical trends and high-growth regions/countries? can Buy Report from Here: Contacthttps://www.meticulousresearch.com/Checkout/27604669Us: Research® Email- sales@meticulousresearch.com Sales- +1-646-781-8004 with us on LinkedIn- https://www.linkedin.com/company/meticulousresearch

 How

 What

Meticulous

The key players operating in the global tissue diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Sigma-Aldrich Co. LLC) (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (U.K.), Becton, Dickinson, and Company (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), BioGenex Laboratories, Inc. (U.S.), Bio SB, INC (U.S.), 3DHISTECH Ltd. (Hungary), and HOLOGIC, INC. (U.S.)

 What

 Who

 What

Page 4 of 5

Connect



Contact

Tissue Diagnostics Market - 2029



 What

Turn static files into dynamic content formats.

Create a flipbook